QUANTINOVA Trademark

Trademark Overview


On Wednesday, October 16, 2013, a trademark application was filed for QUANTINOVA with the United States Patent and Trademark Office. The USPTO has given the QUANTINOVA trademark a serial number of 79144043. The federal status of this trademark filing is SECTION 71 ACCEPTED as of Wednesday, February 19, 2025. This trademark is owned by Qiagen GmbH. The QUANTINOVA trademark is filed in the Chemical Products and Pharmaceutical Products categories with the following description:

Chemical, biochemical and biotechnological products for industrial and scientific purposes, namely, reagents and solvents for scientific and research use in the nature of sample preparation and for conducting marking, separating, isolating, purifying, duplicating and analysis methods for biopolymers, namely, nucleic acids and enzymes; polymerase chain reaction (PCR) reagents for industrial and scientific purposes; chemical reagents for amplification and detection of nucleic acids for industrial and scientific purposes; chemical reagents for real-time and quantitative amplification and detection of nucleic acids for industrial and scientific purposes; chemical reagents for complementary DNA (cDNA) synthesis for scientific research purposes; chemical reagents for amplification and detection of ribonucleic acid (RNA) for scientific research purposes; chemical reagents for conversion of RNA into cDNA for scientific research purposes; test kits comprising chemical preparations for industria...

[Diagnostic reagents for medical and veterinary medical purposes, medical diagnostic reagents for conducting marking, separating, isolating, purifying, duplicating and analysis methods for biopolymers, namely, nucleic acids and enzymes; polymerase chain reaction (PCR) reagents for medical and veterinary medical purposes; reagents for amplification and detection of nucleic acids for medical and veterinary medical purposes; reagents for real-time and quantitative amplification and detection of nucleic acids for medical and veterinary medical purposes; reagents for complementary DNA (cDNA) synthesis for medical and veterinary medical purposes; kits comprising diagnostic preparations for medical and veterinary medical diagnostic purposes, kits comprising medical diagnostic reagents for conducting marking, separating, isolating, purifying, duplicating and analysis methods for biopolymers, namely, nucleic acids; kits comprising polymerase chain reaction (PCR) reagents for medical and veterin...
quantinova

General Information


Serial Number79144043
Word MarkQUANTINOVA
Filing DateWednesday, October 16, 2013
Status706 - SECTION 71 ACCEPTED
Status DateWednesday, February 19, 2025
Registration Number4603851
Registration DateTuesday, September 16, 2014
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 1, 2014

Trademark Statements


Indication of Colors claimedColor is not claimed as a feature of the mark.
Goods and ServicesChemical, biochemical and biotechnological products for industrial and scientific purposes, namely, reagents and solvents for scientific and research use in the nature of sample preparation and for conducting marking, separating, isolating, purifying, duplicating and analysis methods for biopolymers, namely, nucleic acids and enzymes; polymerase chain reaction (PCR) reagents for industrial and scientific purposes; chemical reagents for amplification and detection of nucleic acids for industrial and scientific purposes; chemical reagents for real-time and quantitative amplification and detection of nucleic acids for industrial and scientific purposes; chemical reagents for complementary DNA (cDNA) synthesis for scientific research purposes; chemical reagents for amplification and detection of ribonucleic acid (RNA) for scientific research purposes; chemical reagents for conversion of RNA into cDNA for scientific research purposes; test kits comprising chemical preparations for industrial and scientific purposes, kits comprising reagents and solvents for scientific research use for conducting marking, separating, isolating, purifying, duplicating and analysis methods for biopolymers, namely, nucleic acids, namely, kits comprising polymerase chain reaction (PCR) reagents for industrial and scientific research purposes; chemical reagents for amplification and detection of nucleic acids for industrial and scientific purposes; kits comprising chemical reagents for real-time and quantitative amplification and detection of nucleic acids for industrial and scientific purposes; kits comprising chemical reagents for complementary DNA (cDNA) synthesis for scientific research purposes; kits comprising chemical reagents for amplification and detection of ribonucleic acid (RNA) for scientific research purposes; kits comprising chemical reagents for conversion of RNA into cDNA for scientific research purposes
Goods and Services[Diagnostic reagents for medical and veterinary medical purposes, medical diagnostic reagents for conducting marking, separating, isolating, purifying, duplicating and analysis methods for biopolymers, namely, nucleic acids and enzymes; polymerase chain reaction (PCR) reagents for medical and veterinary medical purposes; reagents for amplification and detection of nucleic acids for medical and veterinary medical purposes; reagents for real-time and quantitative amplification and detection of nucleic acids for medical and veterinary medical purposes; reagents for complementary DNA (cDNA) synthesis for medical and veterinary medical purposes; kits comprising diagnostic preparations for medical and veterinary medical diagnostic purposes, kits comprising medical diagnostic reagents for conducting marking, separating, isolating, purifying, duplicating and analysis methods for biopolymers, namely, nucleic acids; kits comprising polymerase chain reaction (PCR) reagents for medical and veterinary medical purposes; kits comprising reagents for amplification and detection of nucleic acids for medical and veterinary medical purposes; kits comprising reagents for real-time and quantitative amplification and detection of nucleic acids for medical and veterinary medical purposes; kits comprising reagents for complementary DNA (cDNA) synthesis for medical and veterinary medical purposes]
Translation of Words in MarkThe wording "QUANTINOVA" has no meaning in a foreign language.

Classification Information


International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status Code6 - Active
Class Status DateFriday, March 21, 2014
Primary Code001
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status CodeG - NOT AVAILABLE
Class Status DateTuesday, January 5, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameQiagen GmbH
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressHilden 40724
DE

Party NameQiagen GmbH
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressDE

Party NameQiagen GmbH
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressDE

Trademark Events


Event DateEvent Description
Thursday, March 20, 2014SN ASSIGNED FOR SECT 66A APPL FROM IB
Friday, March 21, 2014NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, March 21, 2014ASSIGNED TO EXAMINER
Tuesday, March 25, 2014APPLICATION FILING RECEIPT MAILED
Saturday, March 29, 2014NON-FINAL ACTION WRITTEN
Sunday, March 30, 2014NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Monday, March 31, 2014REFUSAL PROCESSED BY MPU
Monday, March 31, 2014NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Friday, April 18, 2014REFUSAL PROCESSED BY IB
Thursday, May 1, 2014TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, May 14, 2014ASSIGNED TO LIE
Thursday, May 15, 2014CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, May 15, 2014TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, May 15, 2014APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, May 27, 2014LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, June 11, 2014NOTICE OF PUBLICATION
Tuesday, July 1, 2014PUBLISHED FOR OPPOSITION
Friday, August 22, 2014NEW REPRESENTATIVE AT IB RECEIVED
Tuesday, September 16, 2014REGISTERED-PRINCIPAL REGISTER
Tuesday, December 16, 2014FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, February 24, 2015FINAL DISPOSITION PROCESSED
Tuesday, February 24, 2015FINAL DISPOSITION NOTICE SENT TO IB
Friday, March 13, 2015FINAL DECISION TRANSACTION PROCESSED BY IB
Thursday, October 18, 2018NEW REPRESENTATIVE AT IB RECEIVED
Friday, August 21, 2020TEAS SECTION 71 & 15 RECEIVED
Monday, December 7, 2020CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Tuesday, January 5, 2021REGISTERED - PARTIAL SEC. 71 ACCEPTED & SEC. 15 ACK.
Tuesday, January 5, 2021NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
Sunday, September 5, 2021PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
Monday, September 20, 2021INVALIDATION PROCESSED
Monday, September 20, 2021PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Wednesday, November 3, 2021PARTIAL INVALIDATION PROCESSED BY THE IB
Thursday, August 31, 2023INTERNATIONAL REGISTRATION RENEWED
Saturday, September 16, 2023COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
Friday, August 30, 2024TEAS SECTION 71 RECEIVED
Tuesday, February 18, 2025CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Wednesday, February 19, 2025REGISTERED-SEC.71 ACCEPTED
Wednesday, February 19, 2025NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
Sunday, October 19, 2025PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED